___

• Müftüoğlu S, Kaymaz F, Atilla Pergin. Netter Temel Histoloji. 2009 Sayfa: 139-41
• Horton WA. In vitro chondrogenesis in human chondrodysplasias. Am J Med Genet 1993;45:179-82.
• Hakkı SS, Nohutçu RM. Basik Fibroblast Growth Factor (b- FGF) ve Dexamethasone (Dex)’un pre-osteoblastların (MC3T3- E1) proliferasyonu, total protein miktarı ve hücre morfolojisi üzerine etkisi Hacettepe Dişhekimliği Fakültesi Dergisi 2005;29:/4 42-50
• Hakkı SS, Hakkı EE, Akkaya MS. The effects of basic- fFibroblast growth factor(b-FGF) on periodontal Ligament Cells. Journal of Dental Research.2000;79: 2065
• Çetin M, Tapan Y. b-FBF (Bazik Fibroblast Büyüme faktörü) ve formulasyonlarında yeni yaklaşımlar. Hacettepe Üniversitesi Eczacılık Fakültesi Dergisi Cilt 24;2:2004 107-24(C)
• Ornitz DM, Marie PJ. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 2002;16:1446–65.
• Iseki S, Wilkie AO, Morriss-Kay. FGFr1 and FGFr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault. Development 1999; 126:5611–620.
• Shimoaka T, Ogasawara T, Yonamine A, Chikazu D, Kawano H, Nakamura K, Itoh N, Kawaguchi H Regulation of osteoblast, chondrocyte, and osteoclast functions by fibroblast growth factor (FGF)-18 in comparison with FGF-2 and FGF-10. J Biol Chem. 2002;277:7493–500.
• Walsh S, Jefferiss CM, Stewart K, et al. IGF-I does not affect the proliferation or early osteogenic differentiation of human marrow stromal cells. Bone. 2003;33:80–9.
• Fakhry A, Ratisoontorn C, Vedhachalam C, Salhab I, Koyama E, Leboy P, Pacifici M, Kirschner RE, Nah HD Effects of FBF-2/- 9 in calvarial bone cell cultures: differentiation stage-dependent mitogenic effect, inverse regulation of KMP- 2 and noggin and enhancement of osteogenic potential. Bone 2005;36:254–66.
• Noff D, Pitaru S, Savion N. Basic fibroblast growth factor enhances the capacity of bone marrow cells to form bone-like nodules in vitro. FEBS Lett. 1989;250:619–21.
• Pitaru S, Kotev-Emeth S, Noff D, et al. Effect of basic fibroblast growth factor on the growth and differentiation of adult stromal bone marrow cells: enhanced development of mineralized bone- like tissue in culture. J Bone Miner Res. 1993;8:919–29.
• Zhang X, Sobue T, Hurley MM. FGF-2 increases colony formation, PTH receptor, and IGF-1 mRNA in mouse marrow stromal cells. Biochem Biophys Res Commun. 2002;290:526–31.
• Ducy P, Zhang R, Geoffroy V, et al. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997;89:747–54.
• Ducy P, Starbuck M, Priemel M, et al. Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 1999;13:1025–36.
• Komori T, Yagi H, Nomura S, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997;89:755–64.
• Otto F, Thornell AP, Crompton T, et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997;89:765–71.
• 18.Xiao G, Jiang D,Thomas P, et al. MAPK pathways activate and phosphorylate the osteoblast specific transcription factor, Cbfa1. J Biol Chem. 2000;275:4453–59.
• Kim HJ, Lee MH, Park HS, et al. Erk pathway and activator protein 1 play crucial roles in FGF2-stimulated premature cranial suture closure. Dev Dyn 2003;227:335–46.
• Montero A, Okada Y, Tomita M, et al. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest. 2000;105:1085–93.
• Debiais F, Debiais F, Lefèvre G, et al. Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3- kinase-dependent, -beta-catenin-independent signaling pathway. Exp. Cell Res 2004;297:235–46.
• Ohbayashi N, Shibayama M, Kurotaki Y, et al. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev. 2002;16: 870–9.
• Noda M, Vogel R. Fibroblast growth efector enhances type beta 1 transforming growth factor gene expression in osteoblast-like cells. J Cell Biol 1989;109:2529–35.
• Power RA, Iwaniec UT, Wronski TJ. Changes in gene expression associated with the bone anabolic effects of basic fibroblast growth factor in aged ovariectomized rats. Bone 2002; 31;143–8.
• Globus RK, Patterson-Buckendahl P, GospodarowiczD. Regulation of bovine bone cell proliferation by fibroblast growth factor and transforming growth factor beta. Endocrinology 1988;123: 98–105.
• Tang KT, Tang KT, Capparelli C, et al. Acidic fibroblast growth factor inhibits osteoblast differentiation in vitro: altered expression of collagenase, cell growthrelated, and mineralization- associated genes. J. Cell Biochem. 1996;61: 152–66.
• Song H, Kwon K, Lim S, et al. Transfection of mesenchymal stem cells with the FGF-2 gene improves their survival under hypoxic conditions. Mol Cells 2005;19: 402–7.
• Zhou YX, Xu X, Chen L, et al. Pro250Arg substitution in mouse FGFR1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures. Hum Mol Gene 2000;9:2001–8.
• Yu K, Xu J, Liu Z, et al. Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development. 2003; 130:3063–74.
• Deng C, Wynshaw-Boris A, ZhouF, et al. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 1996;84: 911–21
• Murakami S, Balmes G, McKinney S, et al. Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the FGFR3-deficient mouse phenotype. Genes Dev. 2004;18:290–5.
• FunatoN, Ohtani K, Ohyama K, et al. Common regulation of growth arrest and differentiation of osteoblasts by helix-loophelix factors. Mol Cell Biol. 2001;21:7416–28.
• Valverde-Franco G, Valverde-Franco G, Liu H, et al. Defective bone mineralization and osteopenia in young adult FGFR3−/− mice. Hum Mol Genet. 2004;13:271–84.
• Chen L, Adar R, Yang X, et al. Gly369 Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis. J Clin Invest. 1999;104:1517–25.
• Cool S, Jackson R, Pincus P, et al. Fibroblast growth factor receptor 4 (FGFR4) expression in newborn murine calvaria and primary osteoblast cultures. Int J Dev Biol. 2002; 46:519–23.
• Burke D, Wilkes D, Blundell TL, et al. Fibroblast growth factor receptors: lessons from the genes. Trends Biochem. Sci. 1998;23:59–62.
• Muenke M, Schell U. Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet 1995;11:308–13.
• Naski MC, Ornitz DM. FGF signaling in skeletal development. Front Biosci. 1998;3:781–94.
• Webster MK, Donoghue DJ.FGFR activation in skeletal disorders: too much of a good thing. Trends Genet. 1997;13: 178–82.
• Peters K, Ornitz D, Werner S, et al. Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev Biol. 1993;155:423–30.
• Dursun H. Heterotropik Ossifikasyon. FTR Bil Der J PMR Sci 2006;9:69-73
• Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science 1988;42:1528– 34.
• Kronenberg HM. Developmental regulation of the growth plate. Nature 2003;423:332–6.
• Kawabata M, Miyazono K. Bone morphogenetic proteins. In: Canalis MDE (ed) skeletal growth factors. Lippincott Williams & Wilkins, Philadelphia, 2000; 269–90.
• Miyazono K, Maeda S, Imamura T. KMP receptor signaling: transcriptional targets, regulation of signals, and signaling crosstalk. Cytokine growth factor Rev. 2005;16:251–63.
• Karsenty G. Bone morphogenetic proteins and skeletal and nonskeletal development. In: Canalis MDE (ed) skeletal growth factors. Lippincott Williams&Wilkins, Philadelphia,2000; 291– 310.
• Zhang H, Bradley A, at al. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 1996;122:2977–86.
• Winnier G, Blessing M, Labosky PA, et al. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 1995;9:2105–16.
• Daluiski A, Engstrand T, Bahamonde ME, et al. Bone morphogenetic protein-3 is a negative regulator of bone density. Nat Genet 2001;27:84–8.
• Kingsley DM, Bland AE, Grubber JM, et al. The mouse short ear skeletal morphogenesis locus is associated with defects in a bone morphogenetic member of the TGF beta superfamily. Cell. 1992;71:399–10.
• Solloway MJ, Dudley AT, Bikoff EK, et al. Mice lacking KMP6 function. Dev Genet 1998;22:321–39.
• Luo G, Hofmann C, Bronckers AL, et al. KMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev 1995;9:2808–20.
• Minina E, Kresch C, Naski MC,et al. Interaction of FGF, Ihh/Pthlh, and KMP signaling integrates Chondrocyte proliferaiton and hypertrophic differantiation. Derv Cell 2002:3:439-49.
• Lydia Didt-Koziel, Wuelling M, Vortkamp A. Kondrogenez ve osteogenezde büyüme faktörlerinin rolü. Current Opinion in Orthopaedics Türkçe baskı.2006;4:198-207.
• Kugimiya F, Kawaguchi H, Kamekura S, et al. Involvement of endogenous bone morphogenetic protein (BMP)2 and BMP6 in bone formation. J Biol Chem 2005;280:35704–12.
• Cuevas P, et al. Osteopromotion for cranioplasty: an experimental study in rats using acidic fibroblast growth factor Surg Neurol. 1997;47:242–6.
• McCracken M, Lemons JE, Zinn K. Analysis of Ti–6Al–4V implants placed with fibroblast growth factor 1 in rat tibiae. Int J Oral Maxillofac Implants. 2001;16:495–502.
• Nakamura T, et al. Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats. Endocrinology 1995;136: 1276–84.
• Radomsky ML, Aufdemorte TB, Swain LD, et al. Novel formulation of fibroblast growth factor-2 in a hyaluronan gel accelerates fracture healing in nonhuman primates. J Orthop Res 1999;17:607–14.
• Govender S, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J. Bone Jt. Surg. Am. 2002;84:2123–34.